Malignant ascites-derived organoid (MADO) cultures for gastric cancer in vitro modelling and drug screening.

导出原文传递

翻译打印收藏纠错

第一作者： Jie,Li

第一单位： Department of Oncology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China.

作者： Jie,Li ^[1] ; Huawei,Xu ^[1] ; Lixing,Zhang ^[2] ; Lele,Song ^[1] ; Dan,Feng ^[1] ; Xiaobo,Peng ^[1] ; Meihong,Wu ^[1] ; Yang,Zou ^[3] ; Bin,Wang ^[1] ; Lixing,Zhan ^[4] ; Guoqiang,Hua ^[5] ; Xianbao,Zhan ^[6]

作者单位： Department of Oncology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China. ^[1] Research and Early Development, Shanghai 121Biomed Inc, Shanghai, 200235, China. ^[2] Shanghai Key Laboratory of Regulatory Biology, School of Life Sciences, Institute of Biomedical Sciences, East China Normal University, Shanghai, 200241, China. ^[3] CAS Key Laboratory of Nutrition, Metabolism and Food Safety, Shanghai Institute of Nutrition and Health, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of Chinese Academy of Sciences, Shanghai, 200031, China. ^[4] Institute of Radiation Medicine and Fudan University Shanghai Cancer Center, Fudan University, Shanghai, 230032, China. guoqianghua@fudan.edu.cn. ^[5] Department of Oncology, Changhai Hospital, Second Military Medical University, Shanghai, 200433, China. zhan.xianbao@smmu.edu.cn. ^[6]

关键词 Drug screening Gastric cancer Malignant ascites Organoid Personalised medicine